During the past decade, Institute for Pulmonary Disease of Vojvodina conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Pulmonary Disease of Vojvodina" #1 collaborator was "Cystic Fibrosis Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Pulmonary Disease of Vojvodina" are "Pulmonary Arterial Hypertension" (3 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Institute for Pulmonary Disease of Vojvodina" in a lesser frequency.

Most popular intervention types in "Institute for Pulmonary Disease of Vojvodina" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ralinepag" (2 trials), "Lenabasum 20 mg" (1 trials), "Lenabasum 5 mg" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Pulmonary Disease of Vojvodina" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Pulmonary Disease of Vojvodina". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Institute for Pulmonary Disease of Vojvodina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Pulmonary Disease of Vojvodina, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".